Chilean lawmakers support compulsory licensing for coronavirus medicines and vaccines
Concerned about access to treatments for the fast-spreading coronavirus, Chile’s lower house of Congress passed…
Category: Pharmalot
.jpg)
Coronavirus will have a ‘big impact’ on one-third of U.S. clinical trial sites, survey finds
Nearly one-third of clinical trial sites expect the novel coronavirus will have a “big or…
STAT Plus: Pharmalittle: Blood samples are lacking for coronavirus treatments; Europe counters Trump offer to vaccine maker
Good morning, everyone, and welcome to the middle of the week. You made it this…
.jpg)
STAT Plus: Pharmalittle: FDA gives states an OK to authorize coronavirus tests; more companies race to combat Covid-19
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow
Global spending on prescription medicines is forecast to increase between 2% and 5% annually over…
FDA moves to boost coronavirus testing capacity by giving states more power
In response to a dire shortage of tests for detecting the fast-moving coronavirus, the Food…
STAT Plus: Mallinckrodt loses a court case and is told to pay $650 million in overdue Medicaid rebates
In a setback to Mallinckrodt (MNK), a federal court judge upheld a move by the…
STAT Plus: Novartis is scolded by Finnish regulators over hospital sales of a migraine drug
Regulators in Finland threatened to fine Novartis (NVS) for violating laws governing the distribution of…
STAT Plus: Pharmalittle: Will countries nationalize anti-coronavirus supplies? Pandemic halts some academic labs
Good morning, everyone, and welcome to another working week. This week, however, ushers in a…
A new paper about a Gilead drug to combat coronavirus has some analysts skittish about success
As anticipation mounts over the prospects for an experimental Gilead Sciences (GILD) drug to combat…
STAT Plus: Pharmalittle: Drug makers scramble to develop Covid-19 vaccines; Qiagen vows to ramp up production of test chemical
And so, another working week will soon draw to a close. Not a moment too…
A quarantined Ted Cruz proposes to speed approvals for coronavirus drugs and vaccines
Although Sen. Ted Cruz (R-Texas.) is quarantined at home after coming into contact with someone…
STAT Plus: Pharmalittle: A move to fund U.S. production of pharma ingredients; White House issues ‘principles’ for drug pricing reform
Good morning, everyone, and how are you today? We are coping, thank you, despite the…
STAT Plus: Danish regulator eyes sanctions — including prison time — against trial sponsors that fail to post results
In the latest effort toward greater clinical trial transparency, the Danish Medicines Agency is threatening…
STAT Plus: Under pressure, Trump administration looks to cap insulin costs with a Medicare program
The Trump administration announced a new voluntary program that would lower the out-of-pocket cost Medicare…
STAT Plus: Coronavirus fears may slow clinical trials and delay regulatory steps
Initially, plans for the huge clinical trial were proceeding apace. After months of groundwork, about…
STAT Plus: Pharmalittle: Shortage of a key chemical slows coronavirus testing; CMS touts pilot program to lower insulin costs
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
FDA halts inspections of foreign plants through April due to coronavirus
The ongoing spread of the novel coronavirus has prompted the Food and Drug Administration to…
STAT Plus: Pharmalittle: Gates Foundation and others plan $125 million coronavirus effort; India considers lifting export restrictions
Rise and shine, everyone, another busy day is clearly on the way. The world seems…
STAT Plus: Clinical research company sued over stolen trade secrets after employee filmed dogs used in experiments
Nearly two years ago, Charles River Laboratories (CRL) paid $800 million for a company called…
STAT Plus: Debates over biosimilar uptake notwithstanding, sales growth should accelerate by 2024
Despite various issues that have slowed biosimilar uptake by the U.S. health care system, usage…
STAT Plus: A recently approved Gilead HIV prevention pill is not cost-effective and should be cut in half, study says
The price of a Gilead Sciences (GILD) pill approved in the U.S. last fall to…
STAT Plus: Pharmalittle: Will some coronavirus vaccines make infections worse? Not all biopharma execs have prepared
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Former Gates Foundation chief is ‘very worried’ about coronavirus; FDA does little to clarify CBD rules
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Coronavirus vaccine testing starts in Seattle area; New Mexico law caps monthly insulin co-pay at $25
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: Oh, Canada! Vertex battles another country over access to cystic fibrosis treatments
A row has broken out between Vertex Pharmaceuticals (VRTX) and Canadian officials over access to…
STAT Plus: Pharmalittle: Vaccine affordability a roadblock to coronavirus funding; developing a drug costs how much?
Top of the morning to you and a fine one, it is. A shiny sun…
Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates
A simmering feud between the federal government and Mallinckrodt (MNK) took a new turn as…
STAT Plus: Drug prices rose three times faster than inflation over the past decade, despite discounts
Amid intensifying anger over the rising cost of medicines, a key piece of data has…
STAT Plus: New estimate says developing a drug costs $1.3 billion, which is a lot, but less than companies often say
Estimates of how much it cost to invent and test a new medicine have been…
STAT Plus: Pharmalittle: Trump’s contempt for pharma melts away; India restricts exports of 26 ingredients due to coronavirus
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges
In the latest fallout from a federal probe into generic drug price fixing, the Sandoz…
STAT Plus: California slams AmerisourceBergen over opioid shipments to pharmacies
The California Board of Pharmacy cancelled a wholesale license for AmerisourceBergen (ABC) and fined the…
STAT Plus: FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen
An online pharmacy is calling for U.S. regulators to recall batches of the metformin diabetes…
STAT Plus: Pharmalittle: Experts warn political squabbles should not delay coronavirus funding; Gilead to buy Forty Seven for $5 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Sanofi to pay nearly $12 million for illegally using a charity to pay kickbacks to Medicare patients
Sanofi (SNY) has agreed to pay nearly $11.9 million to resolve allegations that donations paid…
STAT Plus: Cardinal Health to pay $8 million for failing to prevent bribes paid in China
Cardinal Health (CAH), one of the largest pharmaceutical wholesalers, agreed to pay more than $8…
STAT Plus: Novartis employee claims she was fired for complaining about incorrect data
As Novartis (NVS) geared up to win approval for a new eye medication that was…
The FDA identifies its first drug shortage due to coronavirus but won’t name the medicine
For the first time since the coronavirus outbreak began, the Food and Drug Administration has…
STAT Plus: Pharmalittle: Azar says Medicare is open to price negotiations; drug makers say opioid settlements are in jeopardy
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Gilead accelerates coronavirus trial; FDA says coronavirus vaccine will take time
Rise and shine, everyone, another busy day is on the way. This is a fast-paced…
STAT Plus: Health care conference about conflicts of interest has a conflict itself, say critics who won’t attend
In an effort to better understand how conflicts of interest may affect health care, the…
STAT Plus: Senators threaten to subpoena Express Scripts for failing to produce insulin documents
The ranking members of the Senate Finance Committee are threatening to issue a subpoena to…
STAT Plus: Tracking pharmaceuticals in the supply chain remains difficult due to sloppy paperwork
As Americans debate whether to import prescription drugs from Canada to relieve rising costs, a…
STAT Plus: Pharmalittle: FDA tracks 20 drugs for shortage risk due to coronavirus; GOP senator moves toward Medicare drug negotiations
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT Plus: An FDA program to ensure decades-old drugs finally get approved is costing billions in price hikes
Back in 2006, the FDA launched an effort to force drug companies to win regulatory…
STAT Plus: Pharmalittle: Moderna ships first batch of coronavirus vaccine; Mallinckrodt to pay $1.6 billion to settle opioid claims
Hello, everyone, and how are you this morning? We are doing just fine, thank you,…
STAT Plus: ICER, the controversial cost-effectiveness watchdog, reverses course on two migraine drugs
In an unusual move, the Institute for Clinical and Economic Review has reversed course and…
STAT Plus: Pharmalittle: Trump aide wants to bring pharma supply chain home; Walgreens hides prescription errors
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Canada may change new rules for drug prices; Trump frustrated over drug pricing
And so, another working week will soon draw to a close. Not a moment too…